IGF-1 gene therapy (Valentis)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIGF-1 gene therapy (Valentis)
Drug Alias NameIGF-1 gene therapy (GeneMedicine)diabetic neuropathy gene therapy (GeneMedicine)diabetic neuropathy gene therapy (Valentis)Insulin-like growth factor Iinsulin-like growth factor-1 gene therapy (GeneMedicine)
ClassificationBiologics
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsUrinary IncontinenceDiabetic NeuropathiesMuscular Atrophy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValentis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenemedicine Co LtdValentis
Active IndicationsN/A
Inactive IndicationsUrinary IncontinenceDiabetic NeuropathiesMuscular Atrophy +[4] 

Other Information

ATC CodeN/A
Related LinksN/A